AU
ProgramOsteoarthritis Treatments Research Consortium
Funds a UK osteoarthritis drug-development consortium, up to £3 million over 5 years.
About
A single-stage process starts with a mandatory Notice of Intention to Apply -- a short PDF naming the consortium and its members -- ahead of the full application through the Arthritis UK Awards Portal. Up to £3 million is available for a single consortium award covering salaries, consumables and equipment over as long as 60 months, with a funding decision expected by March 2027.
BiotechMedtech
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.